Sotera Health Co (SHC)
NASDAQ · Healthcare Services · Services-Misc Health & Allied Services, NEC
- Price
- $18.69
- Day
- -0.05%
- Market cap
- $5.33B
- P/E
- 32.6
Close 2026-09-22.
The company
We are a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. We are driven by our mission: Safeguarding Global Health ® . We provide end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers in the United States and around the world. In 2025, our customers included over 40 of the top 50 medical device companies and nine of the top ten global pharmaceutical companies (based on revenue). Our services are an essential aspect of our customers’ manufacturing processes and supply chains, helping to ensure sterilized medical products reach healthcare practitioners and patients. Most of our services are necessary for our customers to satisfy applicable government requirements. We are a leading global provider of outsourced terminal sterilization and irradiation services and have provided sterilization services for over 90 years. We offer a globally integrated platform for our customers in the medical device, pharmaceutical, food safety, and advanced applications markets, with facilities strategically located to be convenient to our customers’ manufacturing sites and distribution hubs or routes.
By product & service
- Service — 86%
- Product — 14%
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- Sessa Capital IM, L.P. — $480.14M
- Darsana Capital Partners LP — $479.25M
- Sculptor Capital LP — $426M
- Sachem Head Capital Management LP — $276.19M
- BlackRock, Inc. — $256.71M
- VANGUARD CAPITAL MANAGEMENT LLC — $216.03M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $212.05M
- AQR CAPITAL MANAGEMENT LLC — $185.67M
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- Petras Michael B. Jr. (Executive Chairman) sold 294,515 shares at $18.50 on 2026-08-17
- Petras Michael B. Jr. (Executive Chairman) sold 850,000 shares at $18.50 on 2026-08-17
- Rutz Michael P (President of Sterigenics) sold 150,000 shares at $18.84 on 2026-08-07
- Warburg Pincus (Cayman) XI, L.P. (Director,TenPercentOwner) sold 19,102,952 shares at $15.17 on 2026-05-13
- Warburg Pincus XI, L.P. (Director,TenPercentOwner) sold 19,102,952 shares at $15.17 on 2026-05-13
- GTCR FUND XI/C LP (Director,TenPercentOwner) sold 12,735,301 shares at $15.17 on 2026-05-13
Recent filings
- 4 — 2026-08-19
- 144 — 2026-08-17
- 8-K — 2026-08-14
- SCHEDULE 13G/A — 2026-08-14
- SCHEDULE 13G/A — 2026-08-14
- 4 — 2026-08-11
- 4 — 2026-08-07
- 144 — 2026-08-07
- 10-Q — 2026-08-06
- 8-K — 2026-08-06